NCT06596798

Deep Learning Model and Risk Factors for Tacrolimus-related Acute Kidney Injury

Research on the Risk Warning Model and Prevention Strategies for Acute Kidney Injury Associated With Tacrolimus Based on Explainable Deep Neural Networks and Therapeutic Drug Monitoring

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 1,200 (estimated)
• Sponsor: Qianfoshan Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

In this study, the investigators aim to develop a risk prediction model for acute kidney injury (AKI) in hospitalized patients using the calcineurin inhibitor tacrolimus. This will be achieved by mining electronic medical record data and employing explainable deep learning methods. The model will provide clinical decision support for timely intervention and treatment. Compared to traditional machine learning models, deep neural networks can extract more nuanced features from complex medical data and perform more precise pattern recognition, thereby enhancing prediction accuracy and reliability. By constructing a predictive tool based on explainable deep learning models, the investigators will better assess the association between the use of calcineurin inhibitors and AKI, explore targeted prevention strategies, and offer more precise predictions and intervention guidance to clinicians. Additionally, this research has significant socio-economic benefits and application potential. By reducing the incidence of AKI, the investigators can lower patient hospitalization duration and re-treatment costs, conserve medical resources, and improve patient quality of life. Preventive healthcare not only alleviates the physical and psychological burden on patients but also reduces the strain on the healthcare system, enhances healthcare efficiency, and promotes the rational allocation of medical resources.

Conditions

• AKI

Timeline

• Start date: 2024-09-01
• Primary completion: 2026-09-01
• Completion: 2026-12-30
• First posted: 2024-09-19
• Last updated: 2024-09-19

Locations

1 site across 1 country: China